Financials
Financial year 2025
Worth noting
- A loss two years in a row.
- Little cash and receivables against the short-term debts.
Gross margin
€ -2.2 million
Profit
Caution€ -3.3 million
▲ 74% vs 2024
Debts
Low€ 3 million
▲ 60% vs 2024
MAN & SCIENCE from Liège, company number BE0837403770, closed financial year 2025 with a result of € -3.3 million after tax. For that financial year MAN & SCIENCE recorded a gross margin of € -2.2 million and equity of € 2.4 million. Compared with financial year 2024, the result moved from € -12.7 million to € -3.3 million. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.
What happened at MAN & SCIENCE?
What happened at MAN & SCIENCE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- SPARAXIS SA stepped down as director. NBB
- Robert Taub stepped down as director. NBB
- Anneliese Monden stepped down as director. NBB
- Jürgen Hambrecht stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 3.3 million. Source: NBB ↗
- SPARAXIS SA became a director. NBB
- Robert Taub became a director. NBB
- Anneliese Monden became a director. NBB
In short
From € 199,087 loss in 2021 to € 3.3 million loss in 2025.
Paid € 9,957 in corporate taxes since 2021.
Best year ever: 2023, with € 475,933 profit.
A new publication or filing at MAN & SCIENCE? We notify you, reason included.
Follow MAN & SCIENCENeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
It owns 100% of Palion Medical AS itself.
Directors
According to the 2025 annual accounts
Director · represented by Gery Lefebvre
Also active at: C.P. Bourg, A.M.B., Jean Goldschmidt International +228 more
since 2025 · until 2031
Robert Taub
Director
Also active at: SPACE APPLICATIONS SERVICES, EUROPEAN AIRCRAFT PRIVATE CLUB, X-TRA ONE +1 more
since 2025 · until 2031
Jürgen Hambrecht
Director
since 2025 · until 2031
Establishments
Establishment units
Physical locations of this company
Boulevard de Patience et Beaujonc 3 box 24
4000 Liège
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 23 companies are registered at this address.
Hyloris Developments
€ 5.1 million revenue · 2025
ONCORADIOMICS
€ 2.4 million gross margin · 2025
DERMAX
€ 1.6 million revenue · 2025
Hyloris
€ 384,852 revenue · 2025
Hyloris Pharmaceuticals
€ 3.8 million revenue · 2025
+18 more
Details
- Company number
- 0837.403.770
- VAT number
- BE 0837.403.770
- Registered office
- Boulevard de Patience et Beaujonc 3 bus 24, 4000 Liège
- Names & denominations
- MAN & SCIENCE
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 29 June 2011
- Peppol
- Active · Active since 9 Oct 2025
- Activities · NACE
Activiteiten op het gebied van voeding
Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden
Overige menselijke gezondheidszorg, n.e.g.
Groothandel in farmaceutische en medische artikelen
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels